Monosaccharide is the largest biological substance in nature, and glyco chain is the largest biological information carrier in nature. Oligosaccharides are one of the most complex and diverse biological information molecules in organisms.Oligosaccharides are ubiquitous in organisms and participate in all life processes in almost all organisms.
Zhongke RunXin (Suzhou) Biotechnology Co., Ltd. as the National Biochemical Engineering Technology Research Center of the Chinese Academy of Sciences (Beijing) Suzhou Industrial base of the Glyco Bioengineering Research transformation industry platform of the first batch of enterprises, focusing on the Earth's second largest organic substance-chitin (Shrimp crab shell) as raw materials, Using the latest clean green production process to produce polymerization degree, deacetylation degree and acetylation site controllable different functional oligosaccharides, has been built to "shell Oligosaccharide +" as the core strategy of functional health food additives, cosmetic additives, biomedical materials, feed additives, glyco chain plant vaccine industrial base. Runxin has independent intellectual property rights of the core technology and international patents, scientific and technological achievements to reach the advanced level.
At present, the global glyco engineering industry is developing rapidly, and the value chain has become a new way to construct the international division of labor System. The traditional comparative advantage of resource endowment is gradually being lost, and new comparative advantages are being revealed. The new comparative advantages include good market demand, good industrial services and supporting capabilities, as well as the necessary strong driving force for innovation.To be sure, Zhongke Runxin has created its own comparative advantage, so that the core industrial chain and the core technology chain work together, will become a high market share of the series of shell oligosaccharide production enterprises.
At the same time, we look forward to working with domestic and foreign counterparts and scientists in Suzhou Xiangcheng High-tech zone to build a glyco bioengineering industrialization base, to create China's glyco engineering industry Silicon Valley-"Glyco Valley."